Analysis of 8,769 patients revealed that a simple ratio derived from routine bone scans—soft tissue-to-bone ratio (STBR)—independently predicts mortality and cardiovascular events. Patients with STBR above 0.5 showed 73% higher death risk and 51% increased major cardiovascular events over 5.1 years of follow-up, even after adjusting for established risk factors. The ratio correlated with diabetes, kidney disease, heart failure, and inflammatory markers like CRP and NT-proBNP. This finding represents a potentially paradigm-shifting approach to cardiovascular risk assessment. Bone scans are already performed millions of times annually for osteoporosis and cancer screening, making this biomarker immediately accessible without additional testing or radiation exposure. The ability to extract cardiovascular-kidney-metabolic syndrome burden from existing imaging could revolutionize opportunistic screening, particularly valuable given CKM syndrome's role as a leading cause of cardiovascular death. However, this preprint awaits peer review, and the retrospective design limits causal interpretations. The mechanism linking bone metabolism to systemic disease burden requires further investigation, though the monotonic relationship across disease severity suggests biological plausibility.